Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-17

Clinical Trial Update: Gabapentin vs Chlordiazepoxide for Ambulatory Alcohol Withdrawal [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing gabapentin to chlordiazepoxide for ambulatory alcohol withdrawal has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)
  • chlordiazepoxide (chlordiazepoxide)

Snippet

Sponsor: VA Salt Lake City Health Care System | Conditions: Alcohol Withdrawal | Phase 4 | Status: COMPLETED | Results posted: 2020-08-17